Nicotine and endogenous opioids: neurochemical and pharmacological evidence

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733 · see citing works

Public Health Service

Bowman, P. W. (1963) · AIBS Bulletin · doi:10.2307/1292957 · Cited by 3,654 · see citing works

D ₁ and D ₂ Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons

Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967 · see citing works

Clinical Practice Guideline: Otitis Media with Effusion (Update)

Rosenfeld, R. M., Shin, J. J., Schwartz, S. R., Coggins, R., Gagnon, L., Hackell, J. M., Hoelting, D., Hunter, L. L., Kummer, A. W., Payne, S. C., et al. (2016) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599815623467 · Cited by 2,006 · see citing works

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene

Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722 · see citing works

Signs and Symptoms of Tobacco Withdrawal

Hughes, J. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800030107013 · Cited by 1,669 · see citing works

Nicotine addiction

Benowitz, N. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0809890 · Cited by 1,508 · see citing works

Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine

Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · see citing works

Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.

Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D. (1996) · Nature · doi:10.1038/382255a0 · Cited by 1,073 · see citing works

Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat

Wada, E., Wada, K., Boulter, J., Deneris, E. S., Heinemann, S., Patrick, J., & Swanson, L. W. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902840212 · Cited by 1,044 · see citing works

Reward Processing by the Opioid System in the Brain

Le Merrer, J., Becker, J. A. J., Befort, K., & Kieffer, B. L. (2009) · Physiological Reviews · doi:10.1152/physrev.00005.2009 · Cited by 1,013 · see citing works

Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.

Spanagel, R., Herz, A., & Shippenberg, T. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2046 · Cited by 1,005 · see citing works

Autoradiographic differentiation of mu, delta and kappa opioid receptors in the rat forebrain and midbrain

Mansour, A., Khachaturian, H., Lewis, M. E. S., Akil, H., & Watson, S. J. (1988) · Pain · doi:10.1016/0304-3959(88)90103-0 · Cited by 973 · see citing works

Dopamine and drug addiction: the nucleus accumbens shell connection

Di Chiara, G., Bassareo, V., Fenu, S., De Luca, M. A., Spina, L., Cadoni, C., Acquas, E., Carboni, E., Valentini, V., & Lecca, D. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.032 · Cited by 935 · see citing works

Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats.

Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916 · see citing works

A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.

Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880 · see citing works

Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study

Mansour, A., Fox, C. A., Burke, S., Meng, F., Thompson, R. C., Akil, H., & Watson, S. J. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903500307 · Cited by 872 · see citing works

Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens.

Pontieri, F. E., Tanda, G., & Chiara, G. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12304 · Cited by 868 · see citing works

Nucleus Accumbens Deep Brain Stimulation Decreases Ratings of Depression and Anxiety in Treatment-Resistant Depression

Bewernick, B. H., Hurlemann, R., Matusch, A., Kayser, S., Grubert, C., Hadrysiewicz, B., Axmacher, N., Lemke, M., Cooper-Mahkorn, D., Cohen, M. X., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.013 · Cited by 865 · see citing works

Psychotomimesis Mediated by κ Opiate Receptors

Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857 · see citing works

Effects of abstinence from tobacco: Valid symptoms and time course

Hughes, J. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701188919 · Cited by 793 · see citing works

Endogenous opioid systems and alcohol addiction

Herz, A. (1997) · Psychopharmacology · doi:10.1007/s002130050169 · Cited by 749 · see citing works

Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area

Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740 · see citing works

Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats

Imperato, A., Mulas, A., & Di Chiara, G. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90629-1 · Cited by 693 · see citing works

Dramatic decreases in brain reward function during nicotine withdrawal

Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674 · see citing works

Molecular and Physiological Diversity of Nicotinic Acetylcholine Receptors in the Midbrain Dopaminergic Nuclei

Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674 · see citing works

Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses

Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., et al. (2000) · Nature Genetics · doi:10.1038/76061 · Cited by 672 · see citing works

Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study

Gerfen, C. R., & Scott Young, W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91217-6 · Cited by 658 · see citing works

The scientific case that nicotine is addictive

Stolerman, I. P., & Jarvis, M. J. (1995) · Psychopharmacology · doi:10.1007/bf02245088 · Cited by 646 · see citing works

Molecular and cellular aspects of nicotine abuse

Dani, J. A., & Heinemann, S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80112-9 · Cited by 605 · see citing works

The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System

Land, B. B., Bruchas, M. R., Lemos, J. C., Xu, M., Melief, E. J., & Chavkin, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4458-07.2008 · Cited by 601 · see citing works

The immunocytochemical localization of enkephalin in the central nervous system of the rat

Finley, J. C. W., Maderdrut, J. L., & Petrusz, P. (1981) · The Journal of Comparative Neurology · doi:10.1002/cne.901980402 · Cited by 555 · see citing works

The Effects of Opioid Peptides on Dopamine Release in the Nucleus Accumbens: An In Vivo Microdialysis Study

Spanagel, R., Herz, A., & Shippenberg, T. S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04963.x · Cited by 539 · see citing works

Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats

Rossetti, Z. L., Hmaidan, Y., & GESSA, G. L. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90706-a · Cited by 526 · see citing works

Distribution of dynorphin and enkephalin peptides in the rat brain

Fallon, J. H., & Leslie, F. M. (1986) · The Journal of Comparative Neurology · doi:10.1002/cne.902490302 · Cited by 526 · see citing works

Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats.

Bals-Kubik, R., Ableitner, A., Herz, A., & Shippenberg, T. S. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10296-6 · Cited by 525 · see citing works

Systemic nicotine‐induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area

Nisell, M., Nomikos, G. G., & Svensson, T. H. (1994) · Synapse · doi:10.1002/syn.890160105 · Cited by 510 · see citing works

CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli

Barrot, M., Olivier, J. D. A., Perrotti, L. I., DiLeone, R. J., Berton, O., Eisch, A. J., Impey, S., Storm, D. R., Neve, R. L., Yin, J. C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172091899 · Cited by 508 · see citing works

Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis

Gerfen, C. R., McGinty, J. F., & Young, W. S. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-04-01016.1991 · Cited by 506 · see citing works

Subunit Composition of Functional Nicotinic Receptors in Dopaminergic Neurons Investigated with Knock-Out Mice

Champtiaux, N., Gotti, C., Cordero‐Erausquin, M., David, D. J. P., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F., Novère, N. G. L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 505 · see citing works

Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin

König, M., Zimmer, A. M., Steiner, H., Holmes, P. V., Crawley, J. N., Brownstein, M., & Zimmer, A. (1996) · Nature · doi:10.1038/383535a0 · Cited by 486 · see citing works

Structural and functional diversity of native brain neuronal nicotinic receptors

Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469 · see citing works

Nicotine addiction and nicotinic receptors: lessons from genetically modified mice

Changeux, J.-P. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2849 · Cited by 453 · see citing works

κ Opioid Receptor Antagonism and Prodynorphin Gene Disruption Block Stress-Induced Behavioral Responses

McLaughlin, J. P., Marton-Popovici, M., & Chavkin, C. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05674.2003 · Cited by 432 · see citing works

Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal

S. Watkins, G. F. K. (2000) · Nicotine & Tobacco Research · doi:10.1080/14622200050011277 · Cited by 424 · see citing works

Disruption of the κ‐opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ‐agonist U‐50,488H and attenuates morphine withdrawal

Simonin, F., Valverde, O., Smadja, C., Slowe, S., Kitchen, I., Dierich, A., Le Meur, M., Roques, B. P., Maldonado, R., & Kieffer, B. L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.886 · Cited by 418 · see citing works

The GABA Neurons and their axon terminals in rat corpus striatum as demonstrated by GAD immunocytochemistry

Ribak, C. E., Vaughn, J. E., & Roberts, E. (1979) · The Journal of Comparative Neurology · doi:10.1002/cne.901870203 · Cited by 410 · see citing works

Identification of the Nicotinic Receptor Subtypes Expressed on Dopaminergic Terminals in the Rat Striatum

Zoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., & Gotti, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08785.2002 · Cited by 407 · see citing works

The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques

Wacker, J., Dillon, D. G., & Pizzagalli, D. A. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.01.058 · Cited by 405 · see citing works

Subunit Composition and Pharmacology of Two Classes of Striatal Presynaptic Nicotinic Acetylcholine Receptors Mediating Dopamine Release in Mice

Salminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1526 · Cited by 401 · see citing works

Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats

Carlezon, W. A., Béguin, C., DiNieri, J. A., Baumann, M. H., Richards, M. R., Todtenkopf, M. S., Rothman, R. B., Ma, Z., Lee, D. Y.-W., & Cohen, B. M. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092304 · Cited by 390 · see citing works

Neuronal Nicotinic Receptor a6 Subunit mRNA is Selectively Concentrated in Catecholaminergic Nuclei of the Rat Brain

Le Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385 · see citing works

Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.

Devine, D. P., Leone, P., Pocock, D., & Wise, R. A. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39324-9 · Cited by 382 · see citing works

Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior

Steiner, H., & Gerfen, C. R. (1998) · Experimental Brain Research · doi:10.1007/s002210050545 · Cited by 365 · see citing works

Characterization of Nicotinic Receptor‐Mediated [³H]Dopamine Release from Synaptosomes Prepared from Mouse Striatum

Grady, S., Marks, M. J., Wonnacott, S., & Collins, A. C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08322.x · Cited by 350 · see citing works

Molecular biology of the opioid receptors: structures, functions and distributions

Minami, M., & Satoh, M. (1995) · Neuroscience Research · doi:10.1016/0168-0102(95)00933-k · Cited by 345 · see citing works

Nicotine-induced upregulation of nicotinic receptors: Underlying mechanisms and relevance to nicotine addiction

Govind, A. P., Vezina, P., & Green, W. N. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.011 · Cited by 338 · see citing works

Rodent model of nicotine abstinence syndrome

Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90408-8 · Cited by 334 · see citing works

Dynorphin immunocytochemistry in the rat central nervous system

Khachaturian, H., Watson, S. J., Lewis, M. E., Coy, D. H., D, A. G. M., & Akil, H. (1982) · Peptides · doi:10.1016/0196-9781(82)90063-8 · Cited by 320 · see citing works

Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect

Newton, S. S., Thome, J., Wallace, T. L., Shirayama, Y., Schlesinger, L., Sakai, N., Chen, J., Neve, R., Nestler, E. J., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10883.2002 · Cited by 313 · see citing works

Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study

Klitenick, M., DeWitte, P., & Kalivas, P. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02623.1992 · Cited by 309 · see citing works

Stimulation of Endorphin Neurotransmission in the Nucleus Accumbens by Ethanol, Cocaine, and Amphetamine

Olive, M. F., Koenig, H. N., Nannini, M., & Hodge, C. W. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-j0002.2001 · Cited by 300 · see citing works

Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment

Pothos, E., Rada, P., Mark, G. P., & Hoebel, B. G. (1991) · Brain Research · doi:10.1016/0006-8993(91)91724-f · Cited by 288 · see citing works

Presynaptic Nicotinic Modulation of Dopamine Release in the Three Ascending Pathways Studied by In Vivo Microdialysis: Comparison of Naive and Chronic Nicotine‐Treated Rats

Marshall, D. L., Redfern, P. H., & Wonnacott, S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68041511.x · Cited by 284 · see citing works

Comparison of the Distribution of Dynorphin Systems and Enkephalin Systems in Brain

Watson, S. J., Khachaturian, H., Akil, H., Coy, D. H., & D, A. G. M. (1982) · Science · doi:10.1126/science.6128790 · Cited by 279 · see citing works

κ and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release

Mulder, A. H., Wardeh, G., Hogenboom, F., & Frankhuyzen, A. L. (1984) · Nature · doi:10.1038/308278a0 · Cited by 275 · see citing works

Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats

Todtenkopf, M. S., Marcus, J. F., Portoghese, P. S., & Carlezon, W. A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1680-y · Cited by 273 · see citing works

Nicotine: from molecular mechanisms to behaviour

Wonnacott, S., Sidhpura, N., & Balfour, D. J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.12.002 · Cited by 263 · see citing works

Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons

Azam, L., Winzer‐Serhan, U. H., Chen, Y.-L., & Leslie, F. M. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10138 · Cited by 258 · see citing works

Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats

Devine, D. P., & Wise, R. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-04-01978.1994 · Cited by 256 · see citing works

The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum

Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252 · see citing works

Regulation of dopamine release by presynaptic nicotinic receptors in rat striatal slices: Effect of nicotine in a low concentration

Giorguieff, M. F., Kemel, M. L., Wandscheer, D. E., & Glowinski, J. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90469-7 · Cited by 248 · see citing works

Immunocytochemical localization of the α7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system

del Toro, E. D., Juiz, J. M., Peng, X.-D., Lindstrom, J. M., & Criado, M. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903490302 · Cited by 248 · see citing works

Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors

Marubio, L. M., Gardier, A. M., Durier, S., David, D., Klink, R., Arroyo‐Jimenez, M. M., McIntosh, J. M., Rossi, F., Champtiaux, N., Zoli, M., et al. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02564.x · Cited by 242 · see citing works

The endogenous opioid system: A common substrate in drug addiction

Trigo, J. M., Martín‐García, E., Berrendero, F., Robledo, P., & Maldonado, R. J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.011 · Cited by 240 · see citing works

Nicotine induces conditioned place preferences over a large range of doses in rats

Foll, B. L., & Goldberg, S. R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2021-5 · Cited by 229 · see citing works

Nicotinic Acetylcholine Receptors in the Mesolimbic Pathway: Primary Role of Ventral Tegmental Area α6β2* Receptors in Mediating Systemic Nicotine Effects on Dopamine Release, Locomotion, and Reinforcement

Gotti, C., Guiducci, S., Tedesco, V., Corbioli, S., Zanetti, L., Moretti, M., Zanardi, A., Rimondini, R., Mugnaini, M., Clementi, F., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5095-09.2010 · Cited by 226 · see citing works

Morphine-dopamine interaction: Ventral tegmental morphine increases nucleus accumbens dopamine release

Leone, P., Pocock, D., & Wise, R. A. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90210-s · Cited by 226 · see citing works

Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents

Shirayama, Y., & Chaki, S. (2006) · Current Neuropharmacology · doi:10.2174/157015906778520773 · Cited by 225 · see citing works

Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat

Cryan, J. F., Bruijnzeel, A. W., Skjei, K. L., & Markou, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1445-7 · Cited by 223 · see citing works

Attenuation of Nicotine-Induced Antinociception, Rewarding Effects, and Dependence in μ-Opioid Receptor Knock-Out Mice

Berrendero, F., Kieffer, B. L., & Maldonado, R. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10935.2002 · Cited by 222 · see citing works

Characterization of spontaneous and precipitated nicotine withdrawal in the mouse

Damaj, M. I., Kao, W., & Martin, B. R. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054908 · Cited by 222 · see citing works

Reward and Somatic Changes during Precipitated Nicotine Withdrawal in Rats: Centrally and Peripherally Mediated Effects

Watkins, S. S., Stinus, L., Koob, G. F., & Markou, A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35389-3 · Cited by 214 · see citing works

Nicotine as a reinforcer in human subjects and laboratory animals

Henningfield, J. E., & Goldberg, S. R. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90405-7 · Cited by 214 · see citing works

Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens

Angulo, J. A., & McEwen, B. S. (1994) · Brain Research Reviews · doi:10.1016/0165-0173(94)90002-7 · Cited by 213 · see citing works

μ-Opioid Receptor and CREB Activation Are Required for Nicotine Reward

Walters, C. L., Cleck, J. N., Kuo, Y., & Blendy, J. A. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.005 · Cited by 209 · see citing works

N-methyl-d-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens

Schilström, B., Nomikos, G. G., Nisell, M., Hertel, P., & Svensson, T. H. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00243-1 · Cited by 206 · see citing works

Stereoselective Nicotine‐Induced Release of Dopamine from Striatal Synaptosomes: Concentration Dependence and Repetitive Stimulation

RAPIER, C. M., Lunt, G. G., & Wonnacott, S. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10582.x · Cited by 206 · see citing works

Infusion of Nicotine in the Ventral Tegmental Area or the Nucleus Accumbens of the Rat Differentially Affects Accumbal Dopamine Release

Nisell, M., Nomikos, G. G., & Svensson, T. H. (1994) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1994.tb00373.x · Cited by 201 · see citing works

Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome

Hildebrand, B. E., Nomikos, G. G., Hertel, P., Schilström, B., & Svensson, T. H. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01135-9 · Cited by 200 · see citing works

Evidence for the coexistence of glutamate decar☐ylase and Met-enkephalin immunoreactivities in axon terminals of rat ventral pallidum

Zahm, D. S., Záborszky, L., Alones, V., & Heimer, L. (1985) · Brain Research · doi:10.1016/0006-8993(85)90331-2 · Cited by 196 · see citing works

Effects of Nicotine in Experimental Animals and Humans: An Update on Addictive Properties

Foll, B. L., & Goldberg, S. R. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_12 · Cited by 194 · see citing works

Pharmacologic characterization of nicotine-induced conditioned place preference

Fudala, P. J., Teoh, K., & Iwamoto, E. T. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90384-3 · Cited by 190 · see citing works

Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis

Mifsud, J.-C., Hernandez, L., & Hoebel, B. G. (1989) · Brain Research · doi:10.1016/0006-8993(89)91518-7 · Cited by 190 · see citing works

The actions of nicotine and cocaine in a mouse model of anxiety

Costall, B., Elizabeth Kelly, M., Naylor, R. J., & Onaivi, E. S. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90450-4 · Cited by 186 · see citing works

Opioid receptors: From binding sites to visible molecules in vivo

Kieffer, B. L., & Evans, C. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.033 · Cited by 181 · see citing works

Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine

Cadoni, C., & Di Chiara, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00843-2 · Cited by 180 · see citing works

Potential Anxiolytic and Antidepressant-Like Activities of SNC80, a Selective δ-Opioid Agonist, in Behavioral Models in Rodents

Saitoh, A., Kimura, Y., Suzuki, T., Kawai, K., Nagase, H., & Kamei, J. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fpj04014x · Cited by 180 · see citing works

Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs.

Werling, L. L., Frattali, A. L., Portoghese, P. S., Takemori, A. E., & Cox, B. M. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21016-3 · Cited by 177 · see citing works

Nonpeptidic δ-opioid Receptor Agonists Reduce Immobility in the Forced Swim Assay in Rats

Broom, D. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00413-4 · Cited by 175 · see citing works

Effects of abstinence from tobacco: Etiology, animal models, epidemiology, and significance: A subjective review

Hughes, J. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701188927 · Cited by 173 · see citing works

Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area

Charpantier, E., Barnéoud, P., Moser, P. C., Besnard, F., & Sgard, F. (1998) · Neuroreport · doi:10.1097/00001756-199809140-00033 · Cited by 166 · see citing works

Striatal Contributions to Reward and Decision Making: Making Sense of Regional Variations in a Reiterated Processing Matrix

WICKENS, J. R., BUDD, C. S., HYLAND, B. I., & ARBUTHNOTT, G. W. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1390.016 · Cited by 165 · see citing works

Dopamine Signaling Differences in the Nucleus Accumbens and Dorsal Striatum Exploited by Nicotine

Zhang, T., Zhang, L., Liang, Y., Siapas, A. G., Zhou, F.-M., & Dani, J. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0261-09.2009 · Cited by 165 · see citing works

Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: Comparison with caudate-putamen

Brazell, M. P., MITCHELL, S., Joseph, M. H., & Gray, J. A. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90042-p · Cited by 162 · see citing works

Clinical Practice Guideline #5

Pies, R. W. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199502000-00018 · Cited by 159 · see citing works

Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats

Acquas, E., Carboni, E., & Chiara, G. D. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90214-b · Cited by 157 · see citing works

Neuroendocrine reactivity to nicotine in smokers

Pomerleau, O. F., Fertig, J. B., SEYLER, L. E., & Jaffe, J. H. (1983) · Psychopharmacology · doi:10.1007/bf00439275 · Cited by 155 · see citing works

Telencephalic enkephalinergic systems in the rat brain

Khachaturian, H., Lewis, M., Höllt, V., & Watson, S. J. (1983) · Journal of Neuroscience · doi:10.1523/jneurosci.03-04-00844.1983 · Cited by 147 · see citing works

Naloxone precipitates nicotine abstinence syndrome in the rat

Malin, D. H., Lake, J. R., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1993) · Psychopharmacology · doi:10.1007/bf02244930 · Cited by 147 · see citing works

Selective Reward Deficit in Mice Lacking β-Endorphin and Enkephalin

Hayward, M. D., Pintar, J. E., & Low, M. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-18-08251.2002 · Cited by 147 · see citing works

Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats

Foll, B. L., Díaz, J., & Sokoloff, P. (2002) · Synapse · doi:10.1002/syn.10170 · Cited by 147 · see citing works

Nicotine protects against μ-opioid receptor antagonism by β-funaltrexamine: Evidence for nicotine-induced release of endogenous opioids in brain

Davenport, K. E., Houdi, A. A., & Loon, G. R. V. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90491-q · Cited by 145 · see citing works

Delta opioid receptor ligands modulate anxiety‐like behaviors in the rat

Perrine, S. A., Hoshaw, B. A., & Unterwald, E. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706686 · Cited by 144 · see citing works

Evidence That Nicotinic α7 Receptors Are Not Involved in the Hyperlocomotor and Rewarding Effects of Nicotine

Grottick, A. J., Trube, G., Corrigall, W. A., Huwyler, J., Malherbe, P., Wyler, R., & Higgins, G. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39179-7 · Cited by 143 · see citing works

Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine.

Grottick, A. J., Trube, G., Corrigall, W., Huwyler, J., Malherbe, P., Wyler, R., & Higgins, G. A. (2000) · PubMed · Cited by 142 · see citing works

Nicotine-induced conditioned place preference and conditioned place aversion in mice

Risinger, F. O., & Oakes, R. A. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00007-j · Cited by 142 · see citing works

Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens

Rada, P., Jensen, K., & Hoebel, B. (2001) · Psychopharmacology · doi:10.1007/s002130100781 · Cited by 141 · see citing works

Absence of Δ-9-Tetrahydrocannabinol Dysphoric Effects in Dynorphin-Deficient Mice

Zimmer, A., Valjent, E., König, M., Zimmer, A. M., Robledo, P., Hahn, H., Valverde, O., & Maldonado, R. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09499.2001 · Cited by 140 · see citing works

Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system

Berrendero, F., Robledo, P., Trigo, J. M., Martín-García, E., & Maldonado, R. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.02.006 · Cited by 140 · see citing works

μ Opiate Receptor Gene Dose Effects on Different Morphine Actions Evidence for Differential in vivo μ Receptor Reserve

Sora, I. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00252-9 · Cited by 139 · see citing works

Nicotine-Induced Antinociception, Rewarding Effects, and Physical Dependence Are Decreased in Mice Lacking the Preproenkephalin Gene

Berrendero, F., Mendizábal, V. E., Robledo, P., Galeote, L., Bilkei‐Gorzó, A., Zimmer, A., & Maldonado, R. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3008-04.2005 · Cited by 138 · see citing works

Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction

Mineur, Y. S., & Picciotto, M. R. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.010 · Cited by 138 · see citing works

Systemic Nicotine Stimulates Dopamine Release in Nucleus Accumbens: Re-evaluation of the Role ofN-Methyl-d-aspartate Receptors in the Ventral Tegmental Area

Fu, Y., Matta, S. G., Gao, W., Brower, V. G., & Sharp, B. M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39093-7 · Cited by 138 · see citing works

Morphine and δ-opiate agonists locally stimulate in vivo dopamine release in cat caudate nucleus

Chesselet, M., Chéramy, A., Reisine, T., & Glowinski, J. (1981) · Nature · doi:10.1038/291320a0 · Cited by 135 · see citing works

Morphine self-administration in µ-opioid receptor-deficient mice

Becker, A., Grecksch, G., Brödemann, R., Kraus, J., Peters, B., Schröeder, H., Thiemann, W., Loh, H. H., & Höllt, V. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000244 · Cited by 135 · see citing works

Opioid antagonists for smoking cessation

David, S. P., Lancaster, T., Stead, L. F., Evins, A. E., & Prochaska, J. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003086.pub3 · Cited by 132 · see citing works

Nicotinic acetylcholine receptors and the ascending dopamine pathways

Livingstone, P. D., & Wonnacott, S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.004 · Cited by 131 · see citing works

Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice

Fowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131 · see citing works

(D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens

Longoni, R., Spina, L., Mulas, A., Carboni, E., Garau, L., Melchiorri, P., & Chiara, G. D. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01565.1991 · Cited by 126 · see citing works

Modulation of the Behavioral and Neurochemical Effects of Psychostimulants by κ‐Opioid Receptor Systems

Shippenberg, T. S., Chefer, V. I., ZAPATA, A., & Heidbreder, C. A. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03558.x · Cited by 123 · see citing works

Effect of the endogenous ? opioid agonist dynorphin A(1?17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice

Zhang, Y., Butelman, E. R., Schlussman, S. D., Ho, A., & Kreek, M. J. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1688-3 · Cited by 122 · see citing works

β-Endorphin and drug-induced reward and reinforcement

Roth‐Deri, I., Green-Sadan, T., & Yadid, G. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.06.003 · Cited by 117 · see citing works

The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats

Wewers, M. E., Dhatt, R. K., Snively, T. A., & Tejwani, G. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01095-1 · Cited by 111 · see citing works

Opioids and anxiety

Colasanti, A., Rabiner, E. A., Lingford-Hughes, A. R., & Nutt, D. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110367726 · Cited by 111 · see citing works

Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study

Rahman, S., Zhang, J., Engleman, E. A., & Corrigall, W. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.010 · Cited by 110 · see citing works

The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion

Shoaib, M., Gommans, J., Morley, A., Stolerman, I. P., Grailhe, R., & Changeux, J.-P. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00194-0 · Cited by 110 · see citing works

Nicotinic Receptors Modulate Transmitter Cross Talk in the CNS: Nicotinic Modulation of Transmitters

Wonnacott, S., Barik, J., Dickinson, J., & Jones, I. W. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:30:1:137 · Cited by 110 · see citing works

Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat

Mathieu-Kia, A.-M., & Besson, M. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00338-0 · Cited by 108 · see citing works

Differential effects of acute and chronic nicotine on dopamine output in the core and shell of the rat nucleus accumbens

Nisell, M., Marcus, M. M., Nomikos, G. G., & Svensson, T. H. (1997) · Journal of Neural Transmission · doi:10.1007/bf01271290 · Cited by 108 · see citing works

Nicotine-induced alteration in Tyr-Gly-Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity

Houdi, A. A., Pierzchała, K., Marson, L., Palkovits, M., & Loon, G. R. V. (1991) · Peptides · doi:10.1016/0196-9781(91)90183-p · Cited by 104 · see citing works

Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors

Westfall, T. C., Grant, H. L., & Perry, H. (1983) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(83)90037-x · Cited by 102 · see citing works

Behavioral and Biochemical Manifestations of Mecamylamine-Precipitated Nicotine Withdrawal in the Rat Role of Nicotinic Receptors in the Ventral Tegmental Area

Hildebrand, B. E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00055-x · Cited by 102 · see citing works

Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers

Foulds, J. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(96)01327-0 · Cited by 100 · see citing works

The Neuronal Pathways Mediating the Behavioral and Addictive Properties of Nicotine

Balfour, D. J. K. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-69248-5_8 · Cited by 99 · see citing works

Modulation of drug-induced sensitization processes by endogenous opioid systems

Spanagel, R. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(94)00176-g · Cited by 98 · see citing works

Pituitary hormone response to cigarette smoking

SEYLER, L. E., Pomerleau, O. F., Fertig, J. B., Hunt, D., & Parker, K. M. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90062-6 · Cited by 97 · see citing works

Nicotine abstinence in the mouse

Isola, R., Vogelsberg, V., Wemlinger, T. A., Neff, N. H., & Hadjiconstantinou, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02131-9 · Cited by 96 · see citing works

Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats

Carboni, E., Bortone, L., Giua, C., & Di Chiara, G. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00064-2 · Cited by 96 · see citing works

Subjective correlates of cigarette-smoking-induced elevations of peripheral beta-endorphin and cortisol

Gilbert, D. G., Meliska, C. J., Williams, C. L., & Jensen, R. A. (1992) · Psychopharmacology · doi:10.1007/bf02801984 · Cited by 94 · see citing works

Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats

Skjei, K. L., & Markou, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1414-1 · Cited by 93 · see citing works

Mecamylamine-precipitated nicotine-withdrawal aversion in rats

Suzuki, T., Ise, Y., Tsuda, M., Maeda, J., & Misawa, M. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00723-6 · Cited by 93 · see citing works

Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors

Nieto, M. M., Guen, S. L., Kieffer, B. L., Roques, B. P., & Noble, F. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.025 · Cited by 92 · see citing works

The Kappa-Opioid Agonist U69,593 Blocks Cocaine-Induced Enhancement of Brain Stimulation Reward

Tomasiewicz, H. C., Todtenkopf, M. S., Chartoff, E. H., Cohen, B. M., & Carlezon, W. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.029 · Cited by 90 · see citing works

Regional variation in the effects of nicotine on catecholamine overflow in rat brain

Benwell, M. E. M., & Balfour, D. J. K. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00101-5 · Cited by 89 · see citing works

Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist

Vergura, R., Balboni, G., Spagnolo, B., Gavioli, E. C., Lambert, D. G., McDonald, J. L., Trapella, C., Lazarus, L. H., Regoli, D. C., Guerrini, R., et al. (2007) · Peptides · doi:10.1016/j.peptides.2007.10.012 · Cited by 88 · see citing works

Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors

David, V., Besson, M., Changeux, J.-P., Granon, S., & Cazala, P. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.02.003 · Cited by 87 · see citing works

Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse

Jackson, K. J., Carroll, F. I., Negus, S. S., & Damaj, M. I. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1803-1 · Cited by 86 · see citing works

Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens

Hirose, N., Murakawa, K., Takada, K., Oi, Y., Suzuki, T., Nagase, H., Cools, A. R., & Koshikawa, N. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.065 · Cited by 86 · see citing works

Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice

Stoker, A. K., Semenova, S., & Markou, A. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.03.013 · Cited by 85 · see citing works

Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: An in vivo electrochemical study

Pentney, R. J. W., & Gratton, A. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90106-x · Cited by 85 · see citing works

Tolerance to repeated nicotine administration on performance, subjective, and physiological responses in nonsmokers

Heishman, S. J., & Henningfield, J. E. (2000) · Psychopharmacology · doi:10.1007/s002130000541 · Cited by 85 · see citing works

Dynorphin-containing pathways in the substantia nigra and ventral tegmentum: A double labeling study using combined immunofluorescence and retrograde tracing

Fallon, J. H., Leslie, F. M., & Cone, R. I. (1985) · Neuropeptides · doi:10.1016/0143-4179(85)90053-8 · Cited by 82 · see citing works

Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice

Skoubis, P. D., Lam, H. A., Shoblock, J. R., Narayanan, S., & Maidment, N. T. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03956.x · Cited by 82 · see citing works

Preproenkephalin mRNA and Methionine‐Enkephalin Content Are Increased in Mouse Striatum After Treatment with Nicotine

Dhatt, R. K., Gudehithlu, K. P., Wemlinger, T. A., Tejwani, G. A., Neff, N. H., & Hadjiconstantinou, M. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041878.x · Cited by 80 · see citing works

Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell

Paterson, N. E., Balfour, D. J. K., & Markou, A. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05546.x · Cited by 80 · see citing works

Modulation of dopamine release in rat striatal slices by delta opiate agonists.

Lubetzki, C., Chesselet, M. ‐., & Glowinski, J. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33218-0 · Cited by 79 · see citing works

Effects of nicotine on distribution and release of 14C-norepinephrine and 14C-dopamine in rat brain striatum and hypothalamus slices

Goodman, F. R. (1974) · Neuropharmacology · doi:10.1016/0028-3908(74)90093-8 · Cited by 78 · see citing works

Nicotine Psychopharmacology

Henningfield, J. E., London, E. D., & Pogun, S. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5 · Cited by 78 · see citing works

Nicotine-induced alterations in brain regional concentrations of native and cryptic Met- and Leu-enkephalin

Pierzchała, K., Houdi, A. A., & Loon, G. R. V. (1987) · Peptides · doi:10.1016/0196-9781(87)90133-1 · Cited by 76 · see citing works

Identification of the opiosd receptor types mediating β-endorphin-induced alterations in dopamine release in the nucleus accumbens

Spanagel, R., Herz, A., & Shippenberg, T. S. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)94124-g · Cited by 76 · see citing works

Further evidence for a role of δ-opiate receptors in the presynaptic regulation of newly synthesized dopamine release

Petit, F., Hamon, M., Fournié‐Zaluski, M., Roques, B. P., & Glowinski, J. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90731-4 · Cited by 74 · see citing works

Effect of nicotine on in vivo secretion of melanocorticotropic hormones in the rat.

Conte-Devolx, B., Oliver, C., Giraud, P., Gillioz, P., Castanas, E., Lissitzky, J., Boudouresque, F., & Millet, Y. (1981) · Life Science · doi:10.1016/0024-3205(81)90755-4 · Cited by 73 · see citing works

Role of δ-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats

Saitoh, A., Yoshikawa, Y., Onodera, K., & Kamei, J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0112-6 · Cited by 73 · see citing works

Novelty reward as a measure of anhedonia

Bevins, R. A., & Besheer, J. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.013 · Cited by 73 · see citing works

Kappa agonist-induced reduction in dopamine release: site of action and tolerance.

Ba, D., Js, A., Mm, P., & Voigtlander, P. F. V. (1992) · PubMed · Cited by 73 · see citing works

Proopiomelanocortin peptide immunocytochemistry in rhesus monkey brain

Khachaturian, H., Lewis, M. E., Haber, S. N., Akil, H., & Watson, S. J. (1984) · Brain Research Bulletin · doi:10.1016/0361-9230(84)90237-5 · Cited by 72 · see citing works

Receptors in the Ventral Tegmental Area Mediating Nicotine-Induced Dopamine Release in the Nucleus Accumbens

Sziráki, I., Sershen, H. W., Hashim, A., & Lajtha, Á. (2002) · Neurochemical Research · doi:10.1023/a:1014844823534 · Cited by 71 · see citing works

Cellular localization of proenkephalin mRNA in rat brain: gene expression in the caudate-putamen and cerebellar cortex.

Shivers, B. D., Harlan, R. E., Romano, G. J., Howells, R., & Pfaff, D. W. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.6221 · Cited by 70 · see citing works

Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal

Zaniewska, M., McCreary, A. C., Wydra, K., & Filip, M. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.006 · Cited by 68 · see citing works

Mu‐opioid receptors are involved in the tolerance to nicotine antinociception

Galeote, L., Kieffer, B. L., Maldonado, R. J., & Berrendero, F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03751.x · Cited by 65 · see citing works

Modulation of alcohol and nicotine responses through the endogenous opioid system

Drews, E., & Zimmer, A. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.09.004 · Cited by 64 · see citing works

Nicotine withdrawal produces a decrease in extracellular levels of dopamine in the nucleus accumbens that is lower in adolescent versus adult male rats

Natividad, L. A., Tejeda, H. A., Torres, O. V., & O'dell, L. E. (2010) · Synapse · doi:10.1002/syn.20713 · Cited by 64 · see citing works

Comparative immunocytochemical localization of putative opioid ligands in the central nervous system

Stengaard‐Pedersen, K., & Larsson, L. (1981) · Histochemistry and Cell Biology · doi:10.1007/bf00493136 · Cited by 63 · see citing works

Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA

Houdi, A. A., Dasgupta, R., & Kindy, M. S. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00454-5 · Cited by 63 · see citing works

Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats

Ise, Y., Narita, M., Nagase, H., & Suzuki, T. (2000) · Psychopharmacology · doi:10.1007/s002130000482 · Cited by 63 · see citing works

Antagonism of the discriminative and aversive stimulus properties of nicotine in C57BL/6J mice

Gommans, J., Stolerman, I. P., & Shoaib, M. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00130-1 · Cited by 61 · see citing works

Interactions between age and the aversive effects of nicotine withdrawal under mecamylamine-precipitated and spontaneous conditions in male Wistar rats

Shram, M. J., Siu, E. C. K., Li, Z., Tyndale, R. F., & Lê, A. D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1115-x · Cited by 60 · see citing works

Plasma concentrations of beta-endorphin in smokers who consume different numbers of cigarettes per day

Jl, D. A., Muñoz, J. R., Ojeda, L. S., Cascales, A. L., Irles, J. R., Miranda, M. T., Requena, M., & Aguirre, J. C. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00291-4 · Cited by 60 · see citing works

Presynaptic nicotinic receptors modulating neurotransmitter release in the Central Nervous System: Functional interactions with other coexisting receptors

Marchi, M., & Grilli, M. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.004 · Cited by 59 · see citing works

Modulation of Neurotransmitter Release in the Basal Ganglia of the Rat Brain by Dynorphin Peptides

You, Z., Herrera‐Marschitz, M., & Terenius, L. Y. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35036-0 · Cited by 58 · see citing works

Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction

Shippenberg, T. S., LeFevour, A., & Chefer, V. I. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786927813 · Cited by 58 · see citing works

Nicotine anxiogenic and rewarding effects are decreased in mice lacking β-endorphin

Trigo, J. M., Zimmer, A., & Maldonado, R. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.03.013 · Cited by 56 · see citing works

The secretory response of hypothalamic β-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal

Boyadjieva, N. I., & Sarkar, D. K. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00444-x · Cited by 55 · see citing works

Tracking the opioid receptors on the way of desensitization

Marie, N., Aguila, B., & Allouche, S. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.03.015 · Cited by 54 · see citing works

Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice

Balerio, G. N., Aso, E., & Maldonado, R. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2238-y · Cited by 54 · see citing works

Lack of dependence and rewarding effects of deltorphin II in mu-opioid receptor-deficient mice

Hutcheson, D. M., Matthes, H. W. D., Valjent, E., Sánchez‐Blázquez, P., Rodríguez‐Díaz, M., Garzón, J., Kieffer, B. L., & Maldonado, R. J. (2001) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2001.01363.x · Cited by 54 · see citing works

Reduced emotional and corticosterone responses to stress in μ-opioid receptor knockout mice

Ide, S., Sora, I., Ikeda, K., Minami, M., Uhl, G. R., & Ishihara, K. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.005 · Cited by 52 · see citing works

Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum

Isola, R., Zhang, H., Tejwani, G. A., Neff, N. H., & Hadjiconstantinou, M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1315-4 · Cited by 51 · see citing works

EFFECTS OF CHRONIC NICOTINE TREATMENT AND WITHDRAWAL ON HYPOTHALAMIC PROOPIOMELANOCORTIN GENE EXPRESSION AND NEUROENDOCRINE REGULATION

Rasmussen, D. D. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00003-1 · Cited by 51 · see citing works

Reward, addiction, withdrawal to nicotine

De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366 · see citing works

15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse

Charbogne, P., Kieffer, B. L., & Befort, K. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.028 · Cited by 146 · see citing works

Nicotinic, glutamatergic and dopaminergic synaptic transmission and plasticity in the mesocorticolimbic system: Focus on nicotine effects

Pistillo, F., Clementi, F., Zoli, M., & Gotti, C. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.10.002 · Cited by 113 · see citing works

Dopaminergic and cholinergic learning mechanisms in nicotine addiction

Subramaniyan, M., & Dani, J. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12871 · Cited by 103 · see citing works

Prior Exposure to THC Increases the Addictive Effects of Nicotine in Rats

Panlilio, L. V., Zanettini, C., Barnes, C., Solinas, M., & Goldberg, S. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.16 · Cited by 97 · see citing works

The effects of Beta-Endorphin: state change modification

Veening, J. G., & Barendregt, H. P. (2015) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-12-3 · Cited by 84 · see citing works

Opioid System and Alzheimer’s Disease

Cai, Z., & Ratka, A. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8180-3 · Cited by 80 · see citing works

Mechanistic insights into nicotine withdrawal

Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66 · see citing works

Pharmacogenetics of Nicotine Addiction: Role of Dopamine

Herman, A. I., DeVito, E. E., Jensen, K. P., & Sofuoglu, M. (2014) · Pharmacogenomics · doi:10.2217/pgs.13.246 · Cited by 54 · see citing works

Neurophysiology of Nicotine Addiction

Dani, J. A., Jenson, D., & Broussard, J. I. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-001 · Cited by 53 · see citing works

Nicotine and Opioids: a Call for Co-treatment as the Standard of Care

Morris, C. D., & Garver‐Apgar, C. E. (2020) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-020-09712-6 · Cited by 51 · see citing works

Opioid Analgesics and Nicotine: More Than Blowing Smoke

Yoon, J. H., Lane, S. D., & Weaver, M. F. (2015) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2015.1063559 · Cited by 51 · see citing works

Achieving Smoking Cessation Among Persons with Opioid Use Disorder

Vlad, C., Arnsten, J. H., & Nahvi, S. (2020) · CNS Drugs · doi:10.1007/s40263-020-00701-z · Cited by 51 · see citing works

Opioid system in L-DOPA-induced dyskinesia

Pan, J., & Cai, H. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0071-y · Cited by 45 · see citing works

Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers

Kuwabara, H., Heishman, S. J., Brašić, J. R., Contoreggi, C. S., Cascella, N. G., Mackowick, K. M., Taylor, R., ROUSSET, O. G., Willis, W. D., Huestis, M. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113694 · Cited by 43 · see citing works

Emerging drugs for the treatment of tobacco dependence: 2014 update

Elrashidi, M. Y., & Ebbert, J. O. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.899580 · Cited by 42 · see citing works

Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence

Wang, A. L., Elman, I., Lowen, S. B., Blady, S. J., Lynch, K. G., Hyatt, J. M., O’Brien, C. P., & Langleben, D. D. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.20 · Cited by 41 · see citing works

Quit ratios for cigarette smoking among individuals with opioid misuse and opioid use disorder in the United States

Parker, M. A., Weinberger, A. H., & Villanti, A. C. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108164 · Cited by 41 · see citing works

Influence of δ-Opioid Receptors in the Behavioral Effects of Nicotine

Berrendero, F., Plaza‐Zabala, A., Galeote, L., Flores, Á., Bura, S. A., Kieffer, B. L., & Maldonado, R. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.88 · Cited by 40 · see citing works

ALDH1A1 regulates postsynaptic μ–opioid receptor expression in dorsal striatal projection neurons and mitigates dyskinesia through transsynaptic retinoic acid signaling

Pan, J., Yu, J. H., Sun, L., Xie, C., Chang, L., Wu, J., Hawes, S., Sáez-Atiénzar, S., Zheng, W., Kung, J. E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40326-x · Cited by 40 · see citing works

Quantitative Mass Spectrometry Reveals Food Intake-Induced Neuropeptide Level Changes in Rat Brain: Functional Assessment of Selected Neuropeptides as Feeding Regulators

Ye, H., Wang, J., Tian, Z., Ma, F., Dowell, J., Bremer, Q. Z., Lu, G., Baldo, B. A., & Li, L. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000057 · Cited by 38 · see citing works

Can therapeutic strategies prevent and manage dyskinesia in Parkinson’s disease? An update

Leta, V., Jenner, P. G., Chaudhuri, К. R., & Antonini, A. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1681966 · Cited by 39 · see citing works

Varenicline for opioid withdrawal in patients with chronic pain: A randomized, single-blinded, placebo controlled pilot trial

Hooten, W. M., & Warner, D. O. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2014.11.007 · Cited by 37 · see citing works

The influence of stress and early life adversity on addiction: Psychobiological mechanisms of risk and resilience

(2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.012 · Cited by 34 · see citing works

The modulatory role of nicotine on cognitive and non-cognitive functions

Zarrindast, M., & Khakpai, F. (2018) · Brain Research · doi:10.1016/j.brainres.2018.12.002 · Cited by 32 · see citing works

Tobacco alkaloids analyzed by Raman spectroscopy and DFT calculations

Barańśka, M., Dobrowolski, J. C., Kaczor, A., Chruszcz‐Lipska, K., Górz, K., & Ryguła, A. (2012) · Journal of Raman Spectroscopy · doi:10.1002/jrs.3127 · Cited by 33 · see citing works

Activation of PPARγ Attenuates the Expression of Physical and Affective Nicotine Withdrawal Symptoms through Mechanisms Involving Amygdala and Hippocampus Neurotransmission

Domi, E., Caputi, F. F., Romualdi, P., Domi, A., Scuppa, G., Candeletti, S., Atkins, A. L., Heilig, M. A., Demopulos, G. A., Gaitanaris, G., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1922-19.2019 · Cited by 32 · see citing works

Nicotinic Cholinergic System in the Hypothalamus Modulates the Activity of the Hypothalamic Neuropeptides During the Stress Response

Balkan, B., & Pöğün, Ş. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170720092442 · Cited by 32 · see citing works

Association of smoking with μ‐opioid receptor availability before and during naltrexone blockade in alcohol‐dependent subjects

Weerts, E. M., Wand, G. S., Kuwabara, H., Xu, X., Frost, J. J., Wong, D. F., & McCaul, M. E. (2012) · Addiction Biology · doi:10.1111/adb.12022 · Cited by 29 · see citing works

The opioid receptors as targets for drug abuse medication

Noble, F., Lenoir, M., & Marie, N. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13190 · Cited by 29 · see citing works

Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans

Ranganathan, M., Carbuto, M., Braley, G., Elander, J., Perry, E. B., Pittman, B. P., Radhakrishnan, R., Sewell, R. A., & D’Souza, D. C. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001830 · Cited by 27 · see citing works

Chronic Nicotine Treatment Impacts the Regulation of Opioid and Non-opioid Peptides in the Rat Dorsal Striatum

Petruzziello, F., Falasca, S., Andrén, P. E., Rainer, G., & Zhang, X. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.024828 · Cited by 25 · see citing works

Differentially expressed gene (DEG) based protein-protein interaction (PPI) network identifies a spectrum of gene interactome, transcriptome and correlated miRNA in nondisjunction Down syndrome

Ramireddy, S., Sajeed, R., Raghuraman, P., & Sudandiradoss, C. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.09.056 · Cited by 24 · see citing works

Effects of μ‐opioid receptor modulation on the hippocampal network activity of sharp wave and ripples

Giannopoulos, P., & Papatheodoropoulos, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02240.x · Cited by 22 · see citing works

On the Role of Cannabinoid CB1- and μ-Opioid Receptors in Motor Impulsivity

Wiskerke, J., van Mourik, Y., Schetters, D., Schoffelmeer, A. N. M., & Pattij, T. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00108 · Cited by 25 · see citing works

Endogenous opioid system: a promising target for future smoking cessation medications

Norman, H., & D’Souza, M. S. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4582-0 · Cited by 23 · see citing works

From Genes to Treatments: A Systematic Review of the Pharmacogenetics in Smoking Cessation

Salloum, N. C., Buchalter, E. L. F., Chanani, S., Espejo, G. D., Ismail, M. S., Laine, R. O., Nageeb, M., Srivastava, A. B., Trapp, N. T., Trillo, L., et al. (2018) · Pharmacogenomics · doi:10.2217/pgs-2018-0023 · Cited by 23 · see citing works

Class A and C GPCR Dimers in Neurodegenerative Diseases

Moreira, I. S., Caniceiro, A. B., Bueschbell, B., & Schiedel, A. C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220327221830 · Cited by 18 · see citing works

Nicotine-induced changes of brain β-endorphin

Gudehithlu, K. P., Duchemin, A., Tejwani, G. A., Neff, N. H., & Hadjiconstantinou, M. (2012) · Neuropeptides · doi:10.1016/j.npep.2012.03.001 · Cited by 19 · see citing works

Increased Expression of Plasma miRNA-320a and let-7b-5p in Heroin-Dependent Patients and Its Clinical Significance

Liu, H., Xu, W., Feng, J., Ma, H., Zhang, J., Xie, X., Zhuang, D., Shen, W., Liu, H., & Zhou, W. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.679206 · Cited by 18 · see citing works

Elevating levels of the endocannabinoid 2-arachidonoylglycerol blunts opioid reward but not analgesia

Martínez-Rivera, A., Fetcho, R. N., Birmingham, L., Xu, J., Yang, R., Foord, C., Scala-Chávez, D., Mekawy, N., Pleil, K. E., Pickel, V. M., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq4779 · Cited by 17 · see citing works

Acute and chronic modulation of striatal endocannabinoid‐mediated plasticity by nicotine

Adermark, L., Morud, J., Lotfi, A., Ericson, M., & Söderpalm, B. (2018) · Addiction Biology · doi:10.1111/adb.12598 · Cited by 17 · see citing works

Brain region specific modulation of ethanol-induced depression of GABAergic neurons in the brain reward system by the nicotine receptor antagonist mecamylamine

Adermark, L., Söderpalm, B., & Burkhardt, J. M. (2014) · Alcohol · doi:10.1016/j.alcohol.2014.06.004 · Cited by 17 · see citing works

Blunted opioid regulation of the HPA stress response during nicotine withdrawal: therapeutic implications

Al’Absi, M., Nakajima, M., DeAngelis, B. N., Grant, J. E., King, A. C., Grabowski, J. G., Hatsukami, D. K., & ALLEN, S. S. (2020) · Stress · doi:10.1080/10253890.2020.1823367 · Cited by 16 · see citing works

Translational Research on Nicotine Dependence

Falcone, M., Lee, B., Lerman, C. E., & Blendy, J. A. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5005 · Cited by 15 · see citing works

Altered mRNA Levels of Stress-Related Peptides in Mouse Hippocampus and Caudate-Putamen in Withdrawal after Long-Term Intermittent Exposure to Tobacco Smoke or Electronic Cigarette Vapour

Carboni, L., Ponzoni, L., Braida, D., Sala, M., Gotti, C., & Zoli, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020599 · Cited by 15 · see citing works

Gene expression of pro-opiomelanocortin and melanocortin receptors is regulated in the hypothalamus and mesocorticolimbic system following nicotine administration

Tapınc, D. E., Ilgın, R., Kaya, E., Gözen, O., Ugur, M., Koylu, E. O., Kanıt, L., Keser, A., & Balkan, B. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.11.049 · Cited by 14 · see citing works

Opioid receptor types involved in the development of nicotine physical dependence in an invertebrate (Planaria) model

Raffa, R. B., Baron, S., Bhandal, J. S., Brown, T., Song, K., Tallarida, C. S., & Rawls, S. M. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.09.012 · Cited by 14 · see citing works

Neuroscience of nicotine for addiction medicine

D’Souza, M. S. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.07.008 · Cited by 13 · see citing works

Vibrational Circular Dichroism and Theoretical Study of the Conformational Equilibrium in (−)‐S‐Nicotine

Ortega, P. G. R., Montejo, M., & González, J. J. L. (2014) · ChemPhysChem · doi:10.1002/cphc.201402652 · Cited by 13 · see citing works

OPRD1 Genetic Variation and Human Disease

Crist, R. C., & Clarke, T. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_112 · Cited by 12 · see citing works

The Impact of the Opioid Antagonist Naloxone on Experimentally Induced Craving in Nicotine-Dependent Individuals

Krause, D., Warnecke, M., Schütz, C. G., Soyka, M., Manz, K. M., Proebstl, L., Kamp, F., Chrobok, A. I., Pogarell, O. M., & Koller, G. (2018) · European Addiction Research · doi:10.1159/000494346 · Cited by 12 · see citing works

The association between smoking, chronic pain, and prescription opioid use: 2013-2021

Encinosa, W. E., Bernard, D., & Valdez, R. B. (2024) · Journal of Pain · doi:10.1016/j.jpain.2024.104707 · Cited by 10 · see citing works

Altered neurochemical levels in the rat brain following chronic nicotine treatment

Falasca, S., Ranc, V., Petruzziello, F., Khani, A., Kretz, R., Zhang, X., & Rainer, G. (2014) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2014.05.002 · Cited by 10 · see citing works

Memory enhancing effects of nicotine, cocaine, and their conditioned stimuli; effects of beta-adrenergic and dopamine D2 receptor antagonists

Wolter, M., Lapointe, T., Melanson, B., Baidoo, N., Francis, T., Winters, B., & Leri, F. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05884-x · Cited by 11 · see citing works

Nicotine enhancement and reinforcer devaluation: Interaction with opioid receptors

Kirshenbaum, A. P., Suhaka, J. A., Phillips, J. L., & Pinto, M. V. D. S. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.08.003 · Cited by 10 · see citing works

Recent developments in the synthesis of pyridine analogues as a potent anti-Alzheimer's therapeutic leads

Rammohan, A., Bhaskar, B. V., & Zyryanov, G. V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91221-1.00009-9 · Cited by 9 · see citing works

Repeated nicotine exposure modulates prodynorphin and pronociceptin levels in the reward pathway

Carboni, L., Romoli, B., Romualdi, P., & Zoli, M. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.07.002 · Cited by 9 · see citing works

Electroacupuncture inhibits CB1 upregulation induced by ethanol withdrawal in mice

Escosteguy-Neto, J. C., Fallopa, P., Varela, P., Filev, R., Tabosa, Â., & Santos-Junior, J. G. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.05.014 · Cited by 9 · see citing works

Association study of DRD2 A2/A1 , DRD3 Ser9Gly , DβH − 1021C>T , OPRM1 A118G and GRIK1 rs2832407 C>A polymorphisms with alcohol dependence

Ragia, G., Veresies, I., Veresie, L., Veresies, K., & Manolopoulos, V. G. (2016) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2016-0015 · Cited by 9 · see citing works

Molecular Histochemistry Identifies Peptidomic Organization and Reorganization Along Striatal Projection Units

Hishimoto, A., Nomaru, H., Ye, K. Q., Nishi, A., Lim, J., Aguilan, J. T., Nieves, E., Kang, G., Angeletti, R. H., & Hiroi, N. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.09.012 · Cited by 7 · see citing works

Effects of tobacco on affect and craving during opioid addiction recovery: An ecological momentary assessment study

Rhodes, B. E., & Gottfredson, N. C. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106358 · Cited by 7 · see citing works

Dopamine receptors in the anterior cingulate cortex implicate in nicotine enhanced morphine analgesia

Sardari, M., Seddighfar, M., & Sardari, S. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05947-z · Cited by 7 · see citing works

Genetic deletion or pharmacological blockade of nociceptin/orphanin FQ receptors in the ventral tegmental area attenuates nicotine‐motivated behaviour

Domi, A., Lunerti, V., Petrella, M., Domi, E., Borruto, A. M., Ubaldi, M., Weiss, F., & Ciccocioppo, R. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15762 · Cited by 7 · see citing works

Effects of pharmacological manipulation of the kappa opioid receptors on the aversive effects of nicotine

Ward, M., Norman, H., & D’Souza, M. S. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.10.011 · Cited by 6 · see citing works

The influence of stress and social defeat on neurobiological reinforcement mechanisms across reward to withdrawal in nicotine addiction

Shankar, K., Bonnet-Zahedi, S., & George, O. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06852-5 · Cited by 6 · see citing works

Heavy Versus Light Smoking: Its Association With Opioid Use, Chronic Pain, and Mental Health

Encinosa, W. E., Bernard, D., & Valdez, R. B. (2024) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2024.07.010 · Cited by 5 · see citing works

Gene-gene interaction of μ-opioid receptor and GluR5 kainate receptor subunit is associated with smoking behavior in a Greek population: presence of a dose allele effect

Misailidis, G., Ragia, G., Ivanova, D. D., Tavridou, A., & Manolopoulos, V. G. (2015) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmdi-2015-0005 · Cited by 5 · see citing works

Nicotinic Acetylcholine Receptors Along the Habenulo-Interpeduncular Pathway: Roles in Nicotine Withdrawal and Other Aversive Aspects

Dao, D. Q., Salas, R., & Biasi, M. D. (2014) · The Receptors · doi:10.1007/978-1-4939-1167-7_18 · Cited by 5 · see citing works

Melanin-Concentrating Hormone (MCH): Role in Mediating Reward-Motivated and Emotional Behavior and the Behavioral Disturbances Produced by Repeated Exposure to Reward Substances

Karatayev, O., & LEIBOWITZ, S. F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157143 · Cited by 4 · see citing works

Incidence of opioid misuse by cigarette smoking status in the United States

Parker, M. A., Cruz‐Cano, R., Streck, J. M., Ballis, E., & Weinberger, A. H. (2023) · Addictive Behaviors · doi:10.1016/j.addbeh.2023.107837 · Cited by 4 · see citing works

Changes in the expression of hippocampal proteins in rats with recrudescence of morphine addiction

Qiu, H., Gao, Y., Fu, Y., Du, L., Qiu, T., Feng, K., Luo, Q., & Meng, H. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.861 · Cited by 4 · see citing works

Genomic analysis to guide choice of treatment for smoking cessation

David, S. P., Bergen, A. W., Munafo, M. R., Schuit, E., Bennett, D., & Panagiotou, O. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011823 · Cited by 4 · see citing works

Marijuana and Prescription Pain Reliever Use among Cigarette Smokers

Goldberg, R. L., & Cataldo, J. K. (2018) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2018.1506598 · Cited by 3 · see citing works

Emotional and Physical Distress Relief Using a Novel Endorphinergic Formulation

Crain, S., Crain, M. A., & Crain, S. M. (2013) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2013.36046 · Cited by 2 · see citing works

Neurotransmitter Systems and the Nicotine Dependence-Induced Withdrawal Syndrome

Singh, T. G., Sharma, S., & Dhiman, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00019-5

Exposição prolongada de ratos a vareniclina: avaliação comportamental, níveis de neurotransmissores cerebrais e estudo bioquímico e anatomopatológico

Zaccarelli‐Magalhães, J. (2017) · doi:10.11606/d.10.2017.tde-20032017-141445

Influence of Persistence or Cognitive (In)flexibility in Treatment to Quit Smoking

López-Torrecillas, F. (2015) · Addiction & Addictive Disorders · doi:10.24966/aad-7276/100006

Involvement of Opioid Receptors in Nicotine-Related Reinforcement and Pleasure

Kirshenbaum, A. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813035-3.00035-6

Tobacco use Disorder and Chronic Pain: a Narrative Review of Integrated Treatment Approaches, Underlying Mechanisms, and Future Research Directions

Rocha, L. R., Costa, G. P. A., Sofuoglu, M., Castaldelli-Maia, J. M., & Aquino, J. P. D. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00687-y

Regulation of the endogenous opioid system by acute nicotine and nicotine withdrawal

McCarthy, M. J. (2004) · OhioLink ETD Center (Ohio Library and Information Network)

Desensitization of δ-opioid receptors in nucleus accumbens during nicotine withdrawal

McCarthy, M. J., Zhang, H., Neff, N. H., & Hadjiconstantinou, M. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2028-z · Cited by 22 · see citing works

Modulation of opiate receptor binding in striatum and amygdala by selective mesencephalic lesions

Gardner, E. L., Zukin, R. S., & Makman, M. H. (1980) · Brain Research · doi:10.1016/0006-8993(80)91335-9 · Cited by 61 · see citing works

Phasic enkephalinergic modulation of nigrostriatal dopamine metabolism: Potentiation with enkephalinase inhibitors

Wood, P. L. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90566-0 · Cited by 23 · see citing works

Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum

Isola, R., Zhang, H., Tejwani, G. A., Neff, N. H., & Hadjiconstantinou, M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1315-4 · Cited by 51 · see citing works